Hiromichi Kimura
Gründer bei Fast Track Initiative, Inc.
Profil
Hiromichi Kimura is the founder of Fast Track Initiative, Inc. established in 2004.
He is currently the Executive Director & Chief Scientific Officer at The Children's Mercy Hospital, President, Representative Director & Partner at Life Science Management, Inc., Director at AccuRna, Inc., Director at HanaVax, Inc., Director at NeoPhore Ltd., and Outside Director at Braizon Therapeutics, Inc. His former positions include Associate Director & Head-Research at Millennium Pharmaceuticals, Inc. from 2013 to 2014, Associate Director & Research head at Takeda Pharmaceutical Co., Ltd.
from 2007 to 2014, President & Representative Director at HuBit Genomix KK, Senior Director at Astellas Pharma, Inc. from 2014 to 2018, President & Representative Director at Monsanto Japan Ltd., Investment Director at Astellas Venture Management LLC, Director at CellSeed, Inc. from 2001 to 2011, and Director at CYTLIMIC, Inc. He received his doctorate degree from the University of Tokyo in 2000.
Aktive Positionen von Hiromichi Kimura
| Unternehmen | Position | Beginn |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Gründer | 19.03.2004 |
Life Science Management, Inc.
 Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Management, Inc. provides consulting services for businesses in the life science and healthcare industries. The Japanese company's focus is on helping these businesses to succeed and grow. | Präsident | 01.08.2000 |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi. | Direktor/Vorstandsmitglied | - |
The Children's Mercy Hospital
 The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services The Children's Mercy Hospital provides pediatric health care services. It offers abdominal pain program, adolescent medicine, anesthesiology, bioethics, bone marrow transplantation, burn and trauma care, cardiology, child abuse and neglect, cleft palate and craniofacial, dentistry, dermatology, down syndrome clinic, eating disorders center, endocrinology and diabetes, epilepsy center, fetal health center, gastroenterology, genetics, gynecology, hand clinic and surgery, hematology, heart center, imaging, kidney and liver transplant, medical imaging, neonatology, neurology, nutrition services, ophthalmology, pain management, pathology and laboratory medicine, pharmacology, radiology, respiratory care, sexual differentiation treatment, sleep disorders program, surgery, telemedicine, urgent care, urologic surgery, and weight management services. The company was founded in June 1897 and is headquartered in Kansas City, MO. | Corporate Officer/Principal | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hiromichi Kimura
| Unternehmen | Position | Ende |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31.12.2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31.12.2014 |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Hiromichi Kimura
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CELLSEED INC. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Finance |
HuBit Genomix KK
 HuBit Genomix KK Miscellaneous Commercial ServicesCommercial Services HuBit Genomix KK is a Japanese pharmaceutical development company that conducts clinical trials and research on pharmaceuticals to develop diagnostic drugs. The company is based in Tokyo, Japan. The company analyzes and utilize valuable information to create "diagnosis methods" and "pharmaceuticals" that satisfy medical amenities. HuBit Genomix KK was acquired by Celera Group on March 20, 2001. | Commercial Services |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan. | Process Industries |
Life Science Management, Inc.
Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Management, Inc. provides consulting services for businesses in the life science and healthcare industries. The Japanese company's focus is on helping these businesses to succeed and grow. | Commercial Services |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Health Technology |
CYTLIMIC, Inc.
 CYTLIMIC, Inc. BiotechnologyHealth Technology CYTLIMIC, Inc. develops immunotherapy products for the treatment of cancer. It promotes application with pharmaceutical companies. The company was founded on December 16, 2016 and is headquartered in Tokyo, Japan. | Health Technology |
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Phrama Inc founded in 2000. The firm is headquartered in Brisbane, California. | Finance |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
The Children's Mercy Hospital
The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services The Children's Mercy Hospital provides pediatric health care services. It offers abdominal pain program, adolescent medicine, anesthesiology, bioethics, bone marrow transplantation, burn and trauma care, cardiology, child abuse and neglect, cleft palate and craniofacial, dentistry, dermatology, down syndrome clinic, eating disorders center, endocrinology and diabetes, epilepsy center, fetal health center, gastroenterology, genetics, gynecology, hand clinic and surgery, hematology, heart center, imaging, kidney and liver transplant, medical imaging, neonatology, neurology, nutrition services, ophthalmology, pain management, pathology and laboratory medicine, pharmacology, radiology, respiratory care, sexual differentiation treatment, sleep disorders program, surgery, telemedicine, urgent care, urologic surgery, and weight management services. The company was founded in June 1897 and is headquartered in Kansas City, MO. | Health Services |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Commercial Services |
